The IVF Cycle Timeline: How to Map Leave Around Each Phase

A Cycle Is a Project, Not an Appointment

The standard mental model for medical leave is "I have a procedure on Tuesday; I will be back Thursday." IVF does not work that way. A single fresh cycle stretches across roughly six to eight weeks (a description consistent with the patient guidance from ASRM/Reproductive Facts on IVF and the HFEA's IVF treatment overview), involves five to twelve clinic visits, and produces at least three distinct categories of medical incapacity -- short procedural absences, post-procedure recovery, and the longer drain of cumulative side effects from fertility medications.

Mapping leave to that timeline is a project-management exercise as much as a medical one. The wrong default -- treating each appointment as an ad-hoc PTO day -- burns vacation balances quickly and provides no protection if the cycle complicates. The right default is to think of the cycle in phases, match each phase to the legal leave instrument that fits it best, and reserve PTO for the discretionary buffer rather than spending it on appointments that should be PWFA accommodations or FMLA hours.

This article walks through every phase of a typical IVF cycle, from baseline assessment to beta blood draw, and lays out which leave category does what work at each step. It also covers the differences between fresh and frozen cycles, since the leave profile shifts meaningfully when the embryo transfer is decoupled from the retrieval.

This article provides general information about leave rights. It is not legal advice. For your specific situation, consult an employment attorney, your state labor department, or your reproductive endocrinologist's care team.

The Phase Map at a Glance

Before diving into specifics, here is the full cycle laid out as a phase-by-phase table. The leave column identifies the legal instrument that typically fits each phase, in order of preference.

The cumulative footprint, in a typical fresh cycle, is around 20-30 hours of clinic visits plus 2-3 days of full recovery, spread across roughly six to eight weeks. The footprint expands meaningfully if the cycle becomes a frozen embryo transfer cycle (typically adding 2-4 weeks of preparation), if there are complications such as ovarian hyperstimulation syndrome, or if the cycle does not result in pregnancy and a second cycle begins.

Phase 1: Baseline Assessment

The cycle technically begins before the cycle. A baseline ultrasound and bloodwork are typically performed on day 2-3 of menstruation, and many clinics also require a saline sonogram, hysteroscopy, or other imaging in the months before stimulation. These are short visits -- 30-60 minutes including check-in -- but they are scheduled with little lead time because they have to align with the menstrual cycle.

The leave instrument that fits is sick leave if your employer offers it as a separate bank, or a PWFA schedule-flexibility accommodation if you would prefer not to deplete sick leave for what is functionally a routine appointment. Many large employers' sick leave is uncapped or generous enough that using it for a single ultrasound is no real cost, but at companies with tight sick-leave policies the PWFA route preserves the bank for procedure days that need it.

A note on baseline timing: many clinics offer baseline appointments at 6-8 AM specifically to accommodate working patients. If your clinic does, scheduling early visits often eliminates the need for any leave at all. The visit happens before work, and you are at your desk by 9.

Phase 2: Cycle Suppression / Down-Regulation

Some protocols (the long Lupron protocol, in particular) include a week or two of pituitary suppression before stimulation. The patient self-administers daily injections at home. There are typically no clinic visits during this phase. From a leave perspective, this phase is invisible.

Antagonist protocols, which are increasingly the default, skip suppression entirely and go straight from baseline to stimulation. For workers on antagonist protocols, the cycle effectively starts at stimulation.

Phase 3: Stimulation (8-14 Days)

This is the phase that produces the most appointment burden, by a wide margin. During stimulation, the patient self-administers daily injections of follicle-stimulating hormone (FSH) and, mid-cycle, an antagonist to prevent premature ovulation. The clinic monitors response with serial ultrasounds and blood draws -- typically 5 to 7 monitoring visits over 8 to 14 days, scheduled every other day or daily as the cycle progresses.

The visits themselves are short -- 20-40 minutes for the actual ultrasound and blood draw, plus check-in time -- but they are scheduled in the morning and are largely non-negotiable. If the clinic says "come in tomorrow at 7:30," you come in tomorrow at 7:30. The fertility cycle is not flexible about its timing, and missing a visit can compromise the cycle.

The leave question for this phase is the most consequential one in the cycle. There are three approaches:

Approach 1: Burn PTO for each visit. This is the worst option financially and operationally, because 5-7 PTO days disappear quickly into 30-minute appointments, and the year's vacation balance is gone before retrieval even happens.

Approach 2: Use sick leave or intermittent FMLA hours. Better, but FMLA's 12-workweek annual budget (commonly tracked as ~480 hours for a 40-hour-a-week employee under 29 CFR 825.205) can be eroded faster than expected when monitoring visits are logged in full hours rather than fractional ones. Sick leave is usually a cleaner fit, especially in jurisdictions with paid sick leave laws.

Approach 3: PWFA schedule-flexibility accommodation. The best fit for the monitoring phase. The PWFA's accommodation framework is designed precisely for medical appointments that recur frequently and are time-sensitive. A typical accommodation is "schedule flexibility for early-morning medical appointments approximately 2-3 times per week for an 8-12 week period, with make-up time later in the day or week." The accommodation does not consume PTO, sick leave, or FMLA hours. It is treated as a workplace adjustment, not a leave event.

For a deeper dive into whether IVF qualifies as a serious health condition under FMLA, and how the PWFA fills the monitoring-phase gap, see our anchor guide on the topic.

Important: Most monitoring visits do not individually meet FMLA's "more than three consecutive, full calendar days" incapacity threshold under 29 CFR 825.115. They are too short. The PWFA was designed to cover this exact gap and applies to private and public-sector employers with 15 or more employees. If you are at a covered employer, invoking the accommodation framework for the monitoring phase is almost always better than burning FMLA hours.

Phase 4: Trigger Shot

Mid-cycle to late-stimulation, the patient takes a "trigger" injection of human chorionic gonadotropin (hCG) or a GnRH agonist. The trigger is timed precisely -- exactly 36 hours before retrieval -- and is self-administered at home, usually in the evening. It does not affect the workday.

What does affect the workday is the day after the trigger and the morning of retrieval, both of which fall into the next phase.

Phase 5: Egg Retrieval

This is the procedural anchor of the cycle. Retrieval is performed under intravenous sedation in an outpatient surgical setting (sometimes the IVF clinic itself, sometimes an ambulatory surgical center). The procedure itself is 20-30 minutes; the total on-site time, including pre-op prep and post-sedation recovery, is typically 3-4 hours.

After retrieval, virtually all clinics require:

• A driver to take the patient home (sedation prevents driving)
• 24 hours of restricted activity (no driving, no work involving sustained attention, no heavy lifting)
• Often 1-2 days of light bed rest, depending on response and patient sensitivity

For workers, this means a minimum of 2 full days off -- the day of retrieval and the day after -- and many patients take a third day. The leave instrument that fits cleanly is FMLA, since retrieval cycles generally meet the "more than three consecutive, full calendar days" threshold when paired with the cumulative incapacity from stimulation.

Some workers with strong sick-leave benefits use sick leave for these days; this is acceptable as long as you are aware that you are not invoking FMLA's job protection by doing so. A safer pattern is to use FMLA and substitute sick leave or PTO concurrently per your employer's substitution policy, which preserves FMLA's protection while drawing pay from your accrued bank. The mechanics of FMLA-PTO concurrent substitution are covered in detail in our dedicated guide.

For workers with short-term disability coverage, retrieval is the phase where STD typically begins to apply. STD policies generally have a 7-day "elimination period" before benefits begin, which means that for a single retrieval, STD will not pay. STD becomes financially relevant for the recovery phase if there are complications (such as severe ovarian hyperstimulation syndrome) that extend incapacity beyond a week.

Phase 6: Post-Retrieval Recovery and OHSS Monitoring

The two to five days following retrieval are the highest-risk window for ovarian hyperstimulation syndrome (OHSS). Most patients do not develop OHSS, and those who do mostly experience the mild form -- bloating, fluid retention, abdominal discomfort -- that resolves within a week. A small minority develop moderate or severe OHSS, which can require additional medical visits, fluid management, and in rare cases hospitalization.

For leave planning, the practical implication is that the post-retrieval window is the period most likely to require unscheduled additional leave. A worker who plans for 2 days post-retrieval and is fine returns to work as planned. A worker who develops OHSS may need an additional 3-7 days, possibly more.

The right posture is to have FMLA designation and sick-leave / PTO capacity available for this contingency, even if you do not expect to use it. Once the retrieval is FMLA-designated, additional incapacity from the same condition is generally covered by the same designation; you do not have to re-invoke FMLA for OHSS days.

Phase 7: Fertilization Wait / Embryo Development

The 3-7 days between retrieval and transfer is medically quiet. The clinic's lab is fertilizing the eggs and culturing embryos; the patient has no clinic visits, no medications affecting work performance significantly, and -- once the immediate post-retrieval recovery is past -- can usually return to normal activity.

There is a meaningful psychological burden during this window (will any embryos make it to blastocyst? will the genetic test come back normal?), but it is not a medical-leave burden. Most patients work through this phase normally. A small subset choose to take a discretionary PTO day during this window for emotional reasons; that is a personal call rather than a clinical requirement.

Phase 8: Fresh Embryo Transfer (Cycle Day 5-6 After Retrieval)

If the cycle is a fresh transfer -- meaning the embryo is transferred during the same cycle as retrieval, typically 5 days after retrieval at the blastocyst stage -- the transfer itself is a single short procedure. No sedation is required. The procedure is roughly 15-20 minutes, with 30-60 minutes of supine rest afterward. Total time at the clinic is typically 1.5-2 hours.

Most clinics recommend taking the rest of the day easy, but no formal bed rest is medically required (and recent evidence suggests strict bed rest does not improve outcomes). Many patients return to work the next day; some take a single day for transfer and rest.

The leave instrument that fits is a half-day of sick leave, a half-day of FMLA, or a single PTO day. Transfer alone does not typically meet FMLA's three-day incapacity threshold, but when paired with the surrounding cycle (retrieval the week before), the cycle as a whole generally qualifies.

Phase 9: Frozen Embryo Transfer Prep Cycle (Alternative Path)

A growing share of IVF cycles involve frozen embryo transfer (FET) rather than fresh transfer. In an FET cycle, the embryos from retrieval are vitrified (rapidly frozen) and stored. The transfer happens in a subsequent cycle, often weeks or months later. There are several reasons for this:

• Genetic testing (PGT-A, PGT-M) requires biopsy results that take 1-2 weeks
• Avoiding the elevated estrogen levels of a fresh stimulation cycle improves transfer outcomes for many patients
• Severe OHSS risk can lead to "freeze-all" decisions
• Patient preference or scheduling

For leave planning, the FET path adds a second monitoring phase. The frozen transfer prep cycle typically runs 2-4 weeks before the actual transfer and includes:

• An initial baseline ultrasound and bloodwork (1 visit)
• 2-4 monitoring visits during the lining-preparation phase
• The transfer itself

The good news is that the FET monitoring phase is typically less intensive than fresh stimulation -- fewer visits, no daily injections, less cumulative physical impact. The leave profile is closer to "PWFA accommodation for periodic appointments" than to the more burdensome stimulation-phase pattern.

For patients doing multiple transfers from a single retrieval, this is the phase that repeats. A single retrieval might support 2-3 separate FET cycles over 6-12 months, each with its own short prep phase and transfer day.

Phase 10: Frozen Embryo Transfer

Procedurally identical to a fresh transfer: short, no sedation, 1-2 hours at the clinic. The leave fit is the same -- half-day of sick leave, FMLA, or PTO.

The strategic difference is that an FET cycle can be paired with a fresh retrieval cycle in the same year, doubling the cycle count and the leave footprint. Workers planning for a year that includes both retrieval and one or more FETs should map the leave budget across the full sequence rather than the single cycle.

Phase 11: The Two-Week Wait

The 9-14 days between transfer and the first beta hCG blood draw is medically quiet. There are no required clinic visits, no procedures, and -- once the immediate transfer day is past -- no medical incapacity. The patient is technically pregnant from the moment of transfer, in the sense that an embryo is present, but pregnancy is not yet confirmed by hormonal testing.

For most patients, the two-week wait is the most psychologically taxing phase of the cycle. There is no medical lever to pull, no monitoring visit, no productive activity. There is only waiting. Many patients describe it as the hardest phase of an IVF cycle.

There is no formal leave instrument for emotional burden. The PWFA does not cover psychological strain alone. FMLA requires a "serious health condition" with incapacity. PTO is the only generally available lever, and using PTO during the two-week wait is a discretionary choice rather than a clinical necessity. Some workers take a planned long weekend during this window to manage the stress; others continue working normally.

We have written about strategic PTO buffer planning elsewhere. The two-week wait is one of the windows where buffer matters more than the calendar suggests.

Phase 12: Beta hCG Blood Draws

If the cycle has succeeded, the first beta hCG draw confirms pregnancy roughly 9-14 days after transfer. A second beta is typically scheduled 2-3 days later to confirm appropriate hormone doubling, and a third may follow. Each draw is a 15-30 minute clinic visit.

The leave instrument that fits is PWFA accommodation if pregnancy has been confirmed (which by definition it has, if there is a positive beta) or sick leave if you prefer not to invoke PWFA at this stage. The visits are short and time-flexible enough that they often happen before work without any leave at all.

If the beta is negative, the cycle has not resulted in pregnancy, and the patient typically begins the next cycle within 1-2 menstrual cycles. From a leave perspective, this is the moment to take stock: how much FMLA capacity remains, how much sick leave and PTO are available, and whether the next cycle should begin immediately or be deferred.

Cycle-Level Leave Math

For a single fresh cycle with no major complications, a typical leave footprint is:

For a worker with a 480-hour FMLA budget, a single cycle typically consumes 4-8% of the annual budget. A patient running three cycles in a year might use 15-25% of FMLA capacity, leaving substantial room for recovery, pregnancy-related leave if successful, or additional cycles.

The PWFA accommodation, if invoked, does not consume any leave budget at all -- it is treated as a workplace adjustment. This is why front-loading PWFA for monitoring phases is the single highest-leverage move in the leave-planning toolkit.

Differences Between Fresh and Frozen Cycle Years

A worker doing only retrieval-and-fresh-transfer will typically see one major incapacity event per cycle (the retrieval and immediate recovery) and a single transfer day shortly after. A worker doing retrieval-then-frozen-transfer will see the retrieval, then a second monitoring phase weeks or months later, then the transfer. A worker doing multiple FETs from a single retrieval will see additional monitoring + transfer pairs spread across many months.

Most patients underestimate the calendar span on first cycle. The medical literature describes IVF as "a cycle"; the lived experience is that the cycle becomes a sequence, and the sequence becomes a year. Planning leave around the realistic full-year footprint -- not the single-cycle textbook description -- is what prevents PTO depletion mid-treatment.

Cycle Failure and the Next-Cycle Question

If a beta is negative, or if a pregnancy ends in early loss, the cycle is over and the next-cycle decision begins. Clinically, most reproductive endocrinologists recommend at least one menstrual cycle of recovery before beginning a new stimulation. Practically, that puts the next cycle 6-8 weeks out from the failed cycle.

For leave planning, cycle failure is the moment when the Illinois Family Bereavement Leave Act (820 ILCS 154) becomes relevant -- it is one of the few U.S. state statutes that explicitly extends bereavement leave (up to 2 weeks / 10 work days, unpaid, completed within 60 days of the event) to an "unsuccessful round of intrauterine insemination or of an assisted reproductive technology procedure." Eligibility tracks the FMLA-style 12-month / 1,250-hour service threshold and applies to employers with 50 or more employees. For workers in other states, the leave for the failed cycle generally falls under the same FMLA designation that covered the cycle itself.

The emotional and physical recovery from a failed cycle is real, and many workers benefit from a few days of discretionary PTO in the weeks after a negative beta. This is a category of leave that no statute requires but that the experienced cycle veterans we have spoken with consistently identify as important. Plan for it; do not assume the cycle ends with the negative result.

The Year Around the Cycles

The hardest part of IVF leave planning is the year-level view. A worker doing one cycle in a year has a meaningfully different leave allocation problem than a worker doing three. A worker on the FET path is on a different timeline than a worker doing fresh transfers. A worker also planning a wedding, a major work project, or a parent's surgery has cross-cutting demands on the same PTO bank.

The pattern that works for most patients we have heard from is to map the full year forward at the start of treatment, identifying:

• Likely cycle months (with flexibility built in)
• FMLA budget reserved for procedures and recovery
• Sick leave or PWFA accommodations covering monitoring
• Discretionary PTO for emotional buffer, holiday bridge days, and unrelated life events
• Reserve PTO held back for unexpected complications

This is a lot of planning for a year that is also a medical journey. But the alternative -- making leave decisions reactively, cycle-by-cycle -- is the route that produces zero PTO balance halfway through the year and a strained workplace conversation in October about why you have already exhausted your annual allotment.

Closing

An IVF cycle is a six-to-eight-week medical project with a leave footprint that does not match any single legal instrument. PWFA covers the monitoring phase. FMLA covers retrieval and recovery. Sick leave or PTO bridges the rest. The patients who navigate the cycle most cleanly are the ones who have built a phase-by-phase map up front and know which lever to pull at each step.

Try the free optimizer at leavewise.co

The optimizer is built for the year-level planning question rather than the cycle-level one. If you have an IVF year ahead of you, the optimizer can help you identify the bridge days, long weekends, and discretionary windows that will sit alongside whatever protected leave your cycles consume. Treatment will use some days; the optimizer makes sure the rest of the year is still planned.

Disclaimer

This article summarizes US employment-law frameworks (FMLA, PWFA, ADA, state paid leave, state bereavement leave) and the typical clinical structure of an IVF cycle as of May 2026. Laws and regulations change frequently, employer policies vary widely, and clinical protocols differ between practices. Collective agreements, union contracts, short-term-disability policies, and state-specific paid family leave programs may grant rights or impose procedures different from those described here.

Use this article as a starting point, not a legal opinion or medical advice. Before making decisions that depend on your leave entitlements:

• Check DOL FMLA, the EEOC PWFA page, and your state labor department
• Read your employer's specific FMLA, sick leave, short-term disability, and accommodation policies (and any collective bargaining agreement)
• Confirm cycle-specific clinical timelines and restrictions with your reproductive endocrinologist and care team
• Consult a qualified employment attorney for situations involving termination, retaliation, or denied accommodations

Nothing in this article constitutes legal or medical advice or creates an attorney-client or doctor-patient relationship.